Clinical Trials Directory

Trials / Sponsors / Nxera Pharma UK Limited

Nxera Pharma UK Limited

Industry · 14 registered clinical trials.

StatusTrialPhaseStarted
CompletedComparison of Blood Levels of HTL0016878 From an Oral Capsule and an Oral Solution
Healthy Subjects
Phase 12021-07-29
TerminatedA Study in Healthy Subjects to Assess the Safety, Tolerability and Pharmacokinetics of HTL0022562
Healthy
Phase 12021-05-25
CompletedStudy to Investigate the Receptor Occupancy of HTL0014242 Using [18F] FPEB in Healthy Male Subjects
Healthy
Phase 12020-06-29
WithdrawnA Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies
Dementia With Lewy Bodies
Phase 22019-07-01
CompletedA Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310
Healthy
Phase 12019-01-23
CompletedPhase 1, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of mGlu5 NAM HTL0014242
Healthy
Phase 12018-11-14
CompletedMeasurement of HTL0016878 in Cerebrospinal Fluid
Healthy Subjects
Phase 12018-09-26
CompletedMulti-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care
Alzheimer's Disease
Phase 12017-11-10
CompletedA Two Part Study to Assess Safety, PK, PD, and Food Effect of Oral HTL0016878
Healthy
Phase 12017-08-25
CompletedPharmacokinetics of Oral Capsule in Healthy Japanese vs. Caucasian Subjects
Safety Issues, Pharmacokinetics
Phase 12017-05-16
CompletedRelative Bioavailability of HTL0018318 Oral Aqueous Solution Versus Capsules
Bioavailability and Pharmacokinetics
Phase 12016-10-01
CompletedRelative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Do
Alzheimer's Disease
Phase 12016-02-01
CompletedPhase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjec
Alzheimer's Disease
Phase 12015-10-01
CompletedPhase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive I
Alzheimer's Disease
Phase 12013-11-01